Pelvic colorectal recurrence: Crucial role of radiologists in oncologic and surgical treatment options

Cancer Imaging

Volumn 11, Issue SPEC. ISS. A, 2011, Pages

  Georgiou, P A ^a,b   Tekkis, P P ^a,b   Brown, G ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Advanced; Rectal cancer; Recurrent; Staging

Indexed keywords

CANCER CLASSIFICATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; COLONOSCOPY; COLORECTAL CANCER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DISTANT METASTASIS; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PELVIC COLORECTAL CANCER; RECTUM CANCER; REVIEW; SENSITIVITY AND SPECIFICITY; PATHOLOGY; PHYSICIAN ATTITUDE; POSITRON EMISSION TOMOGRAPHY; RADIOLOGY; RECTUM TUMOR; TUMOR RECURRENCE;

HUMANS; MAGNETIC RESONANCE IMAGING; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PHYSICIAN'S ROLE; POSITRON-EMISSION TOMOGRAPHY; RADIOLOGY; RECTAL NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84866768343     PISSN: None     EISSN: 14707330     Source Type: Journal    
DOI: 10.1102/1470-7330.2011.9025     Document Type: Review

References (69)

1. Nicholls RJ, Tekkis PP. Multidisciplinary treatment of cancer of the rectum: a European approach. Surg Oncol Clin N Am 2008; 17: 533-51, viii. doi:10.1016/j.soc.2008.02.008. (Pubitemid 351672071)
2. Boey J, Wong J, Ong GB. Pelvic exenteration for locally advanced colorectal carcinoma. Ann Surg 1982; 195: 513-18. doi:10.1097/ 00000658-198204000-00022. (Pubitemid 12149267)
3. Pilepich MV, Munzenrider JE, Tak WK, Miller HH. Preoperative irradiation of primarily unresectable colorectal carcinoma. Cancer 1978; 42: 1077-81. doi:10.1002/1097-0142(197809)-42:351077::AID-CNCR282042030743.0.CO;2-E. (Pubitemid 9054561)
4. Spratt JS,, Jr Spjut HJ. Prevalence and prognosis of individual clinical and pathologic variables associated with colorectal carcinoma. Cancer 1967; 20: 1976-85. doi:10.1002/1097-0142-(196711)20:1151976::AID-CNCR282020112543.0.CO;2- M.
5. Heriot K. Rectal cancer recurrence: factors and mechanisms. Color Dis 2000; 2: 126-36. doi:10.1046/j.1463-1318.2000-.00148.x.
6. Asoglu O, Karanlik H, Muslumanoglu M, et al. Prognostic and predictive factors after surgical treatment for locally recurrent rectal cancer: a single institute experience. Eur J Surg Oncol 2007; 33: 1199-206. (Pubitemid 350091348)
7. Heriot AG, Byrne CM, Lee P, et al. Extended radical resection: the choice for locally recurrent rectal cancer. Dis Colon Rectum 2008; 51: 284-91. doi:10.1007/s10350-007-9152-9.
8. Rao AR, Kagan AR, Chan PM, Gilbert HA, Nussbaum H, Hintz BL. Patterns of recurrence following curative resection alone for adenocarcinoma of the rectum and sigmoid colon. Cancer 1981; 48: 1492-5. doi:10.1002/1097-0142-(19810915)-48: 651492::AID-CNCR282048063643.0.CO;2-K. (Pubitemid 11042606)
9. Phillips RK, Hittinger R, Blesovsky L, Fry JS, Fielding LP. Local recurrence following-curative-surgery for large bowel cancer: II. The rectum and rectosigmoid. Br J Surg 1984; 71: 17-20. doi:10.1002/bjs.1800710105. (Pubitemid 14214646)
10. Cass AW, Million RR, Pfaff WW. Patterns of recurrence following surgery alone for adenocarcinoma of the colon and rectum. Cancer 1976; 37: 2861-5. doi:10.1002/1097-0142(197606)-37:652861::AID-CNCR282037064343.0.CO;2-3.
11. Paterson C, Nelson H. Surgical approach to locally recurrent disease. In: Audisio RA, Geraghty JG, Longo WE, editors. Modern management of cancer of the rectum. London: Springer-Verlag; 2001, p. 147-56.
12. Rifkin MD, Ehrlich SM, Marks G. Staging of rectal carcinoma: prospective comparison of endorectal US and CT. Radiology 1989; 170: 319-22. (Pubitemid 19035646)
13. Beynon J, Mortensen NJ, Foy DM, Channer JL, Rigby H, Virjee J. The detection and evaluation of locally recurrent rectal cancer with rectal endosonography. Dis Colon Rectum 1989; 32: 509-17. doi:10.1007/BF02554508. (Pubitemid 19148683)
14. Puli SR, Bechtold ML, Reddy JB, Choudhary A, Antillon MR, Brugge WR. How good is endoscopic ultrasound in differentiating various T stages of rectal cancer? Meta-analysis and systematic review. Ann Surg Oncol 2009; 16: 254-65. doi:10.1245/s10434-008-0231-5.
15. Kruskal JB, Kane RA, Sentovich SM, Longmaid HE. Pitfalls and sources of error in staging rectal cancer with endorectal us. Radiographics 1997; 17: 609-26. (Pubitemid 127465380)
16. Moss AA, Thoeni RF, Schnyder P, Margulis AR. Value of computed tomography in the detection and staging of recurrent rectal carcinomas. J Comput Assist Tomogr 1981; 5: 870-4. doi:-10.1097/00004728-198112000-00016. (Pubitemid 12229454)
17. Adalsteinsson B, Glimelius B, Graffman S, Hemmingsson A, Pahlman L, Rimsten A. Computed tomography of recurrent rectal carcinoma. Acta Radiol Diagn (Stockh) 1981; 22: 669-72. (Pubitemid 12190658)
18. Grabbe E, Winkler R. Local recurrence after sphincter-saving resection for rectal and rectosigmoid carcinoma. Value of various diagnostic methods. Radiology 1985; 155: 305-10. (Pubitemid 15038712)
19. Thompson WM, Halvorsen RA, Foster WL,, Jr. Roberts L, Gibbons R. Preoperative and postoperative CT staging of rectosigmoid carcinoma. AJR Am J Roentgenol 1986; 146: 703-10. (Pubitemid 16117259)
20. Farouk R, Nelson H, Radice E, Mercill S, Gunderson L. Accuracy of computed tomography in determining resectability for locally advanced primary or recurrent colorectal cancers. Am J Surg 1998; 175: 283-7. doi:10.1016/S0002- 9610(98)00017-8. (Pubitemid 28183550)
21. Heriot AG, Tekkis PP, Darzi A, Mackay J. Surgery for local recurrence of rectal cancer. Colorectal Dis 2006; 8: 733-47. doi:10.1111/j.1463-1318.2006. 01018.x. (Pubitemid 44541701)
22. Blomqvist L, Holm T, Goranson H, Jacobsson H, Ohlsen H, Larsson SA. MR imaging, CT and CEA scintigraphy in the diagnosis of local recurrence of rectal carcinoma. Acta Radiol 1996; 37: 779-84. doi:10.3109/02841859609177716. (Pubitemid 126710175)
23. Balzarini L, Ceglia E, D-Ippolito G, Petrillo R, Tess JD, Musumeci R. Local recurrence of rectosigmoid cancer: what about the choice of MRI for diagnosis? Gastrointest Radiol 1990; 15: 338-42. doi:10.1007/BF01888814. (Pubitemid 20259903)
24. Pema PJ, Bennett WF, Bova JG, Warman P. CT vs MRI in diagnosis of recurrent rectosigmoid carcinoma. J Comput Assist Tomogr 1994; 18: 256-61. doi:10.1097/00004728-199403000-00016. (Pubitemid 24100013)
25. Messiou C, Chalmers AG, Boyle K, Wilson D, Sagar P. Pre-operative MR assessment of recurrent rectal cancer. Br J Radiol 2008; 81: 468-73. doi:10.1259/bjr/53300246. (Pubitemid 351957758)
26. Dicle O, Obuz F, Cakmakci H. Differentiation of recurrent rectal cancer and scarring with dynamic MR imaging. Br J Radiol 1999; 72: 1155-9. (Pubitemid 30028927)
27. Huebner RH, Park KC, Shepherd JE, et al. A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer. J Nucl Med 2000; 41: 1177-89. (Pubitemid 30464000)
28. Zhang C, Chen Y, Xue H, et al. Diagnostic value of FDG-PET in recurrent colorectal carcinoma: a meta-analysis. Int J Cancer 2009; 124: 167-73. doi:10.1002/ijc.23926.
29. Moore HG, Akhurst T, Larson SM, Minsky BD, Mazumdar M, Guillem JG. A case-controlled study of 18-fluorodeoxyglucose positron emission tomography in the detection of pelvic recurrence in previously irradiated rectal cancer patients. J Am Coll Surg 2003; 197: 22-8. doi:10.1016/S1072-7515(03)00337-5. (Pubitemid 36759175)
30. von Schulthess GK, Steinert HC, Hany TF. Integrated PET/CT: current applications and future directions. Radiology 2006; 238: 405-22. doi:10.1148/radiol.2382041977. (Pubitemid 43134354)
31. Kamel IR, Cohade C, Neyman E, Fishman EK, Wahl RL. Incremental value of CT in PET/CT of patients with colorectal carcinoma. Abdom Imaging 2004; 29: 663-8. doi:10.1007/ s00261-003-0163-2. (Pubitemid 39331699)
32. Even-Sapir E, Parag Y, Lerman H, et al. Detection of recurrence in patients with rectal cancer: PET/CT after abdominoperineal or anterior resection. Radiology 2004; 232: 815-22. doi:10.1148/ radiol.2323031065. (Pubitemid 39100268)
33. Vliegen RF, Beets-Tan RG, Vanhauten B, et al. Can an FDGPET/ CT predict tumor clearance of the mesorectal fascia after preoperative chemoradiation of locally advanced rectal cancer? Strahlenther Onkol 2008; 184: 457-64. doi:10.1007/s00066-008-1858-7.
34. Kristiansen C, Loft A, Berthelsen AK, et al. PET/CT and histopathologic response to preoperative chemoradiation therapy in locally advanced rectal cancer. Dis Colon Rectum 2008; 51: 21-5. doi:10.1007/s10350-007-9095-1.
35. Capirci C, Rampin L, Erba PA, et al. Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neoadjuvant chemo-radiation therapy. Eur J Nucl Med Mol Imaging 2007; 34: 1583-93. doi:10.1007/s00259-007-0426-1. (Pubitemid 47476915)
36. Suzuki K, Dozois RR, Devine RM, et al. Curative reoperations for locally recurrent rectal cancer. Dis Colon Rectum 1996; 39: 730-6. doi:10.1007/ BF02054435. (Pubitemid 26243965)
37. Yamada K, Ishizawa T, Niwa K, Chuman Y, Akiba S, Aikou T. Patterns of pelvic invasion are prognostic in the treatment of locally recurrent rectal cancer. Br J Surg 2001; 88: 988-93. doi:10.1046/j.0007-1323.2001.01811.x. (Pubitemid 34015583)
38. Wanebo HJ, Antoniuk P, Koness RJ, et al. Pelvic resection of recurrent rectal cancer: technical considerations and outcomes. Dis Colon Rectum 1999; 42: 1438-48. doi:10.1007/ BF02235044. (Pubitemid 29532088)
39. Sobin LH, Fleming ID. TNM classification of malignant tumors, fifth edition. Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer 1997; 80: 1803-4. doi:10.1002/(SICI)1097-0142(19971101)-80: 951803::-AID-CNCR1643.0.CO;2-9.
40. Guillem J, Ruo L. Strategies in operative therapy for locally recurrent rectal cancer. Semin Colon Rectal Cancer 1998; 9: 259-68. (Pubitemid 29024773)
41. Moore HG, Shoup M, Riedel E, et al. Colorectal cancer pelvic recurrences: determinants of resectability. Dis Colon Rectum 2004; 47: 1599-606. doi:10.1007/s10350-004-0677-x. (Pubitemid 39331969)
42. Moore H, Harrison L, Guillem J. Cancer of the rectum: follow up and management of local recurrence. In: Fazio VW, Church JM, Delaney CP, editors. Current therapy in colon and rectal surgery. 2nd ed. Philadelphia, PA: Elsevier Mosby; 2005. p. 185-90.
43. Georgiou P, Brown G, Constantinides V, Antoniou A, Nicholls RJ, Tekkis PP. Diagnostic accuracy of MRI in assessing tumor invasion within pelvic compartments in recurrent and locally advanced rectal cancer. Dis Colon Rectum 2009; 52: 9.
44. Ward BA, Miller DL, Frank JA, et al. Prospective evaluation of hepatic imaging studies in the detection of colorectal metastases: correlation with surgical findings. Surgery 1989; 105: 180-7. (Pubitemid 19071124)
45. Floriani I, Torri V, Rulli E, et al. Performance of imaging modalities in diagnosis of liver metastases from colorectal cancer: a systematic review and meta-analysis. J Magn Reson Imaging 2010; 31: 19-31. doi:10.1002/jmri.22010.
46. Falk PM, Gupta NC, Thorson AG, et al. Positron emission tomography for preoperative staging of colorectal carcinoma. Dis Colon Rectum 1994; 37: 153-6. doi:10.1007/BF02047538. (Pubitemid 24083066)
47. Abdel-Nabi H, Doerr RJ, Lamonica DM, et al. Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose wholebody PET: correlation with histopathologic and CT findings. Radiology 1998; 206: 755-60. (Pubitemid 28128526)
48. Ogunbiyi OA, Flanagan FL, Dehdashti F, et al. Detection of recurrent and metastatic colorectal cancer: comparison of positron emission tomography and computed tomography. Ann Surg Oncol 1997; 4: 613-20. doi:10.1007/BF02303744. (Pubitemid 127725488)
49. Mukai M, Sadahiro S, Yasuda S, et al. Preoperative evaluation by whole-body 18F-fluorodeoxyglucose positron emission tomography in patients with primary colorectal cancer. Oncol Rep 2000; 7: 85-7.
50. Meta J, Seltzer M, Schiepers C, et al. Impact of 18F-FDG PET on managing patients with colorectal cancer: the referring physician-s perspective. J Nucl Med 2001; 42: 586-90. (Pubitemid 32298278)
51. Kalff V, Hicks RJ, Ware RE, Hogg A, Binns D, McKenzie AF. The clinical impact of (18)F-FDG PET in patients with suspected or confirmed recurrence of colorectal cancer: a prospective study. J Nucl Med 2002; 43: 492-9. (Pubitemid 34286344)
52. Potter KC, Husband JE, Houghton SL, Thomas K, Brown G. Diagnostic accuracy of serial CT/magnetic resonance imaging review vs. positron emission tomography/CT in colorectal cancer patients with suspected and known recurrence. Dis Colon Rectum 2009; 52: 253-9. doi:10.1007/DCR.0b013e31819d11e6.
53. Paterson C, Nelson H. Surgical approach to locally recurrent disease. In: Audisio R, Geraghty J, Longo W, editors. Modern management of cancer of the rectum. London: Springer-Verlag; 1998. p. 147-56.
54. Huguier M, Houry S. Treatment of local recurrence of rectal cancer. Am J Surg 1998; 175: 288-92. doi:10.1016/S0002-9610(98)00016-6. (Pubitemid 28183551)
55. Maetani S, Onodera H, Nishikawa T, et al. Significance of local recurrence of rectal cancer as a local or disseminated disease. Br J Surg V; 85: 521-5. doi:10.1046/j.1365-2168.1998.00602.x.
56. Hartley JE, Lopez RA, Paty PB, Wong WD, Cohen AM, Guillem JG. Resection of locally recurrent colorectal cancer in the presence of distant metastases: can it be justified? Ann Surg Oncol 2003; 10: 227-33. doi:10.1245/ASO.2003.05. 039. (Pubitemid 40486954)
57. Moriya Y, Akasu T, Fujita S, Yamamoto S. Total pelvic exenteration with distal sacrectomy for fixed recurrent rectal cancer in the pelvis. Dis Colon Rectum 2004; 47: 2047-53; discussion 2053-4. doi:10.1007/s10350-004-0714-9. (Pubitemid 40179063)
58. Hahnloser D, Nelson H, Gunderson LL, et al. Curative potential of multimodality therapy for locally recurrent rectal cancer. Ann Surg 2003; 237: 502-8. doi:10.1097/00000658-200304000-00011. (Pubitemid 38176430)
59. Garcia-Aguilar J, Cromwell JW, Marra C, Lee SH, Madoff RD, Rothenberger DA. Treatment of locally recurrent rectal cancer. Dis Colon Rectum 2001; 44: 1743-8. doi:10.1007/BF02234449. (Pubitemid 34031429)
60. Sagar PM, Gonsalves S, Heath RM, Phillips N, Chalmers AG. Composite abdominosacral resection for recurrent rectal cancer. Br J Surg 2009; 96: 191-6. doi:10.1002/bjs.6464.
61. Shoup M, Guillem JG, Alektiar KM, et al. Predictors of survival in recurrent rectal cancer after resection and intraoperative radiotherapy. Dis Colon Rectum 2002; 45: 585-92. doi:10.1007/ s10350-004-6250-9. (Pubitemid 34507231)
62. Yeung RS, Moffat FL, Falk RE. Pelvic exenteration for recurrent colorectal carcinoma: a review. Cancer Invest 1994; 12: 176-88. doi:10.3109/07357909409024873. (Pubitemid 24120467)
63. Cheng C, Rodriguez-Bigas MA, Petrelli N. Is there a role for curative surgery for pelvic recurrence from rectal carcinoma in the presence of hydronephrosis? Am J Surg 2001; 182: 274-7. doi:10.1016/S0002-9610(01)00706-1. (Pubitemid 32918376)
64. Mannaerts GH, Rutten HJ, Martijn H, Groen GJ, Hanssens PE, Wiggers T. Abdominosacral resection for primary irresectable and locally recurrent rectal cancer. Dis Colon Rectum 2001; 44: 806-14. doi:10.1007/BF02234699. (Pubitemid 32522068)
65. Suzuki K, Gunderson LL, Devine RM, et al. Intraoperative irradiation after palliative surgery for locally recurrent rectal cancer. Cancer 1995; 75: 939-52. doi:10.1002/1097-0142(19950215)-75:45939::AID-CNCR282075040843.0.CO;2-E.
66. Yeung RS, Moffat FL, Falk RE. Pelvic exenteration for recurrent and extensive primary colorectal adenocarcinoma. Cancer 1993; 72: 1853-8. doi:10.1002/1097-0142(19930915)72:651853::AIDCNCR282072061143.0. CO;2-V. (Pubitemid 23262111)
67. Brophy PF, Hoffman JP, Eisenberg BL. The role of palliative pelvic exenteration. Am J Surg 1994; 167: 386-90. doi:10.1016/ 0002-9610(94)90121-X. (Pubitemid 24186176)
68. Belluco C, Melega E, Mammano E, Pucciarelli S, Nitti D, Lise M. Multimodality management of recurrent rectal cancer. Clin Colon Rectal Surg 2002; 15: 63. doi:10.1055/s-2002-23569.
69. Miner TJ, Jaques DP, Paty PB, Guillem JG, Wong WD. Symptom control in patients with locally recurrent rectal cancer. Ann Surg Oncol 2003; 10: 72-9. doi:10.1245/ASO.2003.03.040.